UK Modern Slavery Act

Swedish Orphan Biovitrum Ltd statement in Adherence to the UK Modern Slavery Act 2015

Organisation structure, business and supply chain

Swedish Orphan Biovitrum Ltd (“Sobi”) is the UK subsidiary of Swedish Orphan Biovitrum AB, the parent company of the Sobi Group, headquartered in Stockholm, Sweden.  The Sobi organisation spans 25 countries and delivers treatments for Haemophilia, rare diseases and specialty indications in over 60 countries across the globe.

Sobi is an integrated biotechnology company with in-house capabilities that encompass the entire value chain from research to pre-clinical and clinical development, biologics manufacturing and supply, to patient access and distribution.  Sobi also partners with several pharmaceutical companies to deliver treatments developed in the rare disease area.

 

Policies in relation to slavery and human trafficking

Sustainability is fundamental to Sobi’s business.  A sustainable business entails a commitment to responsibility for patients and employees as well as reducing environmental impact from operations and treatment, as well as long-term sustainable profitability.  Sobi supports and respects the protection of internationally adopted human and labour rights, and this is enshrined in the Group’s Code of Conduct which explicitly sets out our zero tolerance policy to child labour and forced labour.  Sobi supports the United Nations position on human rights, labour standards, environmental protection and the fight against corruption.

Sobi’s Supplier Code of Conduct requires all of Sobi’s suppliers to treat all indivdiuals with respect and fairness, to observe basic human rights, and to adhere to all relevant employment legislation applicable including laws on minimum wage and working conditions, and the Universal Declaration of Human Rights of the United Nations. 

 

Due Diligence, risk management and risk assessment

Sobi takes its responsibility seriously and regularly reviews its measures in its supply chain in relation to human rights, ethical conduct and personal data protection.  Sobi requires all of its suppliers to subscribe to its Code of Conduct and Ethics, and to formally agree to maintaining compliance with all applicable laws relating to safety, health, environment, competition and anti-trust, human rights, fair labour practices, unlawful discrimination and anti-bribery/anti-corruption, including without limitation,

  • The United Nations Universal Declaration of Human Rights (1948);
  • The Eight Fundamental Conventions of the International Labor Organization, no. 29, 87, 98, 100, 105, 111, 138 and 182;
  • The United Nations Convention on the Rights of the Child, Article 32;
  • The labour protection and labour environment legislation in force in the country of production;
  • The labour law, including legislation on minimum wages, and the social welfare protection regulations in force in the country of production;
  • The environmental protection legislation that is in force in the country of production; and
  • The United Nations Convention against Corruption

 

Effectiveness, communication and training

In order to ensure Sobi’s suppliers’ adherence to the Sobi Code of Conduct, any employee performing due diligence on a supplier is required to report any deviation from the Code of Conduct to Sobi’s Legal and Procurement teams.  Consequences of concerns confirmed may range from discussions with suppliers about remedial measures up to the suspension or termination of a supply relationship.

In addition to suppliers subscribing to Sobi’s Code of Conduct, every new employee of Sobi has to acknowledge Sobi’s Code of Conduct as part of the on-boarding and induction process.  Sobi provides online training for employees covering compliance with Sobi’s Code of Conduct and requires that all employees sign off their awareness and training on all relevant topics.

UK Modern Slavery Act

Swedish Orphan Biovitrum Ltd statement in Adherence to the UK Modern Slavery Act 2015

Organisation structure, business and supply chain

Swedish Orphan Biovitrum Ltd (“Sobi”) is the UK subsidiary of Swedish Orphan Biovitrum AB, the parent company of the Sobi Group, headquartered in Stockholm, Sweden.  The Sobi organisation spans 25 countries and delivers treatments for Haemophilia, rare diseases and specialty indications in over 60 countries across the globe.

Sobi is an integrated biotechnology company with in-house capabilities that encompass the entire value chain from research to pre-clinical and clinical development, biologics manufacturing and supply, to patient access and distribution.  Sobi also partners with several pharmaceutical companies to deliver treatments developed in the rare disease area.

 

Policies in relation to slavery and human trafficking

Sustainability is fundamental to Sobi’s business.  A sustainable business entails a commitment to responsibility for patients and employees as well as reducing environmental impact from operations and treatment, as well as long-term sustainable profitability.  Sobi supports and respects the protection of internationally adopted human and labour rights, and this is enshrined in the Group’s Code of Conduct which explicitly sets out our zero tolerance policy to child labour and forced labour.  Sobi supports the United Nations position on human rights, labour standards, environmental protection and the fight against corruption.

Sobi’s Supplier Code of Conduct requires all of Sobi’s suppliers to treat all indivdiuals with respect and fairness, to observe basic human rights, and to adhere to all relevant employment legislation applicable including laws on minimum wage and working conditions, and the Universal Declaration of Human Rights of the United Nations. 

 

Due Diligence, risk management and risk assessment

Sobi takes its responsibility seriously and regularly reviews its measures in its supply chain in relation to human rights, ethical conduct and personal data protection.  Sobi requires all of its suppliers to subscribe to its Code of Conduct and Ethics, and to formally agree to maintaining compliance with all applicable laws relating to safety, health, environment, competition and anti-trust, human rights, fair labour practices, unlawful discrimination and anti-bribery/anti-corruption, including without limitation,

  • The United Nations Universal Declaration of Human Rights (1948);
  • The Eight Fundamental Conventions of the International Labor Organization, no. 29, 87, 98, 100, 105, 111, 138 and 182;
  • The United Nations Convention on the Rights of the Child, Article 32;
  • The labour protection and labour environment legislation in force in the country of production;
  • The labour law, including legislation on minimum wages, and the social welfare protection regulations in force in the country of production;
  • The environmental protection legislation that is in force in the country of production; and
  • The United Nations Convention against Corruption

 

Effectiveness, communication and training

In order to ensure Sobi’s suppliers’ adherence to the Sobi Code of Conduct, any employee performing due diligence on a supplier is required to report any deviation from the Code of Conduct to Sobi’s Legal and Procurement teams.  Consequences of concerns confirmed may range from discussions with suppliers about remedial measures up to the suspension or termination of a supply relationship.

In addition to suppliers subscribing to Sobi’s Code of Conduct, every new employee of Sobi has to acknowledge Sobi’s Code of Conduct as part of the on-boarding and induction process.  Sobi provides online training for employees covering compliance with Sobi’s Code of Conduct and requires that all employees sign off their awareness and training on all relevant topics.